Happy Monday! The day before the election, we said we would give a shoutout to whichever reader correctly guessed the final Electoral College tally. Congratulations Denise Cote, you called it!
Quick Hits: Today’s Top Stories
Pfizer and BioNTech on Friday submitted an application for emergency use authorization for their coronavirus vaccine candidate to the Food and Drug Administration (FDA). “While we cannot predict how long the FDA’s review will take,” the agency said in a statement, “the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner, so that we can help make available a vaccine that the American people deserve as soon as possible.”
The makers of a third leading COVID vaccine candidate, AstraZeneca and the University of Oxford, announced early Monday that their vaccine was between 62 and 90 percent effective (depending on the dosage administered) in preventing the disease in late-stage trials.
The FDA also issued an emergency use authorization for Regeneron’s antibody treatment to combat mild to moderate COVID-19 in patients who are at high risk of developing more severe symptoms.